News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Cantor Fitzgerald 2015 Healthcare Conference

BOULDER, Colo., July 6, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cantor Fitzgerald 2015 Healthcare Conference in New York City.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Array BioPharma

 

Event:

Cantor Fitzgerald 2015 Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer

Date:

Wednesday, July 8, 2015

Time:

1:00 p.m. Eastern Time

Webcast:

www.arraybiopharma.com

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Six Phase 3 studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca).  For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-cantor-fitzgerald-2015-healthcare-conference-300109222.html

SOURCE Array BioPharma Inc.